You just read:

Jazz Pharmaceuticals and Nippon Shinyaku Enter Into License Agreements for the Development and Commercialization of Defitelio and Vyxeos in Japan

News provided by

Jazz Pharmaceuticals plc

Mar 30, 2017, 02:00 ET